Entera Bio (ENTX) Shares Outstanding (2017 - 2026)

Entera Bio (ENTX) has reported Shares Outstanding (Entity) for 10 consecutive years, with $46.6 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.65% year-over-year to $46.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.6 million (up 2.65% YoY) and the FY2025 annual result came in at $149700.0, down 99.61% from the prior year.
• Shares Outstanding (Entity) grew to $46.6 million in Q1 2026 per ENTX's latest filing, from $149700.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ENTX reached as high as $46.6 million in Q1 2026 and fell as low as $149700.0 in Q4 2025.
• A 5-year average of $33.0 million and a median of $29.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 33.89% — and 2025, when it plunged 99.61%.
• Year by year, Shares Outstanding (Entity) stood at $28.8 million in 2022, then rose by 0.69% to $29.0 million in 2023, then jumped by 33.89% to $38.8 million in 2024, then tumbled by 99.61% to $149700.0 in 2025, then jumped by 31043.78% to $46.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $46.6 million, $149700.0, and $45.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.